3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine

C20H28ClN7O2 — CID 144945580

IUPAC3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine
SMILESCOc1cc(N2CCN(C)CC2)c(N)cc1Nc1ncc(Cl)c(OC2CN(C)C2)n1
InChIInChI=1S/C20H28ClN7O2/c1-26-4-6-28(7-5-26)17-9-18(29-3)16(8-15(17)22)24-20-23-10-14(21)19(25-20)30-13-11-27(2)12-13/h8-10,13H,4-7,11-12,22H2,1-3H3,(H,23,24,25)
InChIKeyKYKIAEMUYMINPN-UHFFFAOYSA-N
MW433.94 g/mol
LogP1.91
Rot. Bonds6

About 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine

3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine (PubChem CID 144945580) has the molecular formula C20H28ClN7O2 and a molecular weight of 433.94 g/mol. Its IUPAC name is 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine.

Molecular Properties

Compound Name3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine
PubChem CID144945580
Molecular FormulaC20H28ClN7O2
Molecular Weight433.94 g/mol
Exact Mass433.20
IUPAC Name3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine
SMILESCOc1cc(N2CCN(C)CC2)c(N)cc1Nc1ncc(Cl)c(OC2CN(C)C2)n1
InChIInChI=1S/C20H28ClN7O2/c1-26-4-6-28(7-5-26)17-9-18(29-3)16(8-15(17)22)24-20-23-10-14(21)19(25-20)30-13-11-27(2)12-13/h8-10,13H,4-7,11-12,22H2,1-3H3,(H,23,24,25)
InChIKeyKYKIAEMUYMINPN-UHFFFAOYSA-N
XLogP1.91
TPSA92.01 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500433.94
LogP ≤ 51.91
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine?
The IUPAC name of 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine (CID 144945580) is 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine.
What is the SMILES notation for 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine?
The canonical SMILES for 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine is COc1cc(N2CCN(C)CC2)c(N)cc1Nc1ncc(Cl)c(OC2CN(C)C2)n1.
What is the InChIKey of 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine?
The InChIKey is KYKIAEMUYMINPN-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H28ClN7O2/c1-26-4-6-28(7-5-26)17-9-18(29-3)16(8-15(17)22)24-20-23-10-14(21)19(25-20)30-13-11-27(2)12-13/h8-10,13H,4-7,11-12,22H2,1-3H3,(H,23,24,25).
What are the key properties of 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine?
3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine has a molecular weight of 433.94 g/mol, XLogP of 1.91, 6 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-N-[5-chloro-4-(1-methylazetidin-3-yl)oxypyrimidin-2-yl]-4-methoxy-6-(4-methylpiperazin-1-yl)benzene-1,3-diamine is sourced from PubChem (CID 144945580), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).